| 摘要 |
The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-tL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma. |
